Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity.

MLA

Flury, Philipp, et al. “Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity.” ACS Pharmacology & Translational Science, vol. 7, no. 2, Jan. 2024, pp. 493–514. EBSCOhost, https://doi.org/10.1021/acsptsci.3c00313.

APA

Flury, P., Breidenbach, J., Krüger, N., Voget, R., Schäkel, L., Si, Y., Krasniqi, V., Calistri, S., Olfert, M., Sylvester, K., Rocha, C., Ditzinger, R., Rasch, A., Pöhlmann, S., Kronenberger, T., Poso, A., Rox, K., Laufer, S. A., Müller, C. E., … Pillaiyar, T. (2024). Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity. ACS Pharmacology & Translational Science, 7(2), 493–514. https://doi.org/10.1021/acsptsci.3c00313

Chicago

Flury, Philipp, Julian Breidenbach, Nadine Krüger, Rabea Voget, Laura Schäkel, Yaoyao Si, Vesa Krasniqi, et al. 2024. “Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity.” ACS Pharmacology & Translational Science 7 (2): 493–514. doi:10.1021/acsptsci.3c00313.